(PRESS RELEASE) LONDON, 13-Jan-2020 — /EuropaWire/ — Schroders announces the appointment of Yves Desjardins as Country Head of France. Yves will lead and further develop Schroders’ activities in France. He will report to Karine Szenberg, Head of Europe at Schroders.
Yves joined Schroders‘ institutional sales team in June 2015 and was appointed Head of institutional sales in 2018. Yves’ career in asset management goes way back in 2001 when he started as an international equity trader in Sinopia Asset Management (HSBC-CCF Group). Before joining Schroders, Yves was a relationship manager covering French and Dutch institutional clients at HSBC Global Asset Management before being appointed Head of the institutional team in 2012 with a particular focus on pension funds and insurers.
“Yves has successfully led our institutional business in France over the last two years, in line with our strategy of developing private assets and dedicated solutions. His experience and knowledge of the market give him all the assets he needs to succeed in this new role. His appointment will allow me to fully concentrate on my duties as Head of Europe, a strategic region that combines large mature markets and promising growth areas.
Supporting talent is one of the Group’s values, and we are delighted to give our employees the opportunity to develop internally,” commented Karine Szenberg, Head of Europe, Schroders.
In the recent years, Schroders’ Paris office has grown steadily. As of 30 June 2019, its AUM was 9.3 billion euros. The French office has 68 employees in Distribution, now headed by Yves and three areas of investment, infrastructure debt, commercial real estate and hotel real estate.
For inquiries:
Nathaele Rebondy
+33 1 53 85 85 17
nathaele.rebondy@Schroders.com
Claire Guermond
+33 1 79 74 80 13
claire@steeleandholt.com
Gaetan Pierret
+33 6 30 75 44 07
gaetan@steeleandholt.com
SOURCE: Schroders
(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its…
(IN BRIEF) Last Friday, NMB Bank Plc celebrated the listing of its dual-currency sustainability bond,…
(IN BRIEF) CapMan Nordic Infrastructure II fund has reached its final closing at over €375…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated…
(IN BRIEF) AstraZeneca's Truqap, in combination with Faslodex, has received a positive recommendation from the…
(IN BRIEF) Ørsted, a global leader in renewable energy, is divesting its French onshore operations…